We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Gold Supplier
Immunoassay Analyzer
RoboBlot™ Non-Heated
SARS-CoV-2 & Influenza Test
cobas SARS-CoV-2 & Influenza A/B Test
SARS-CoV-2 Antigen Test
2019-nCoV Antigen Test (Lateral Flow Method)
Respiratory SARS-CoV-2 Panel
QIAstat-Dx Respiratory SARS-CoV-2 Panel
Visit expo >

Download Mobile App


Innovative Molecular Detection System Offers On-Site and Rapid Detection of SARS-CoV-2

A compact and robust molecular detection system based on the isothermal DNA/RNA amplification method can provide on-site and rapid detection of SARS-CoV-2, making it ideal for use in airports, sport venues, pharmacies and workplaces due to its simple and fast operation procedure. More...
13 Jan 2021

Distinct Blood Signatures Found in COVID-19 Patients Could Significantly Improve Testing

Researchers have discovered distinct blood signatures present in patients with COVID-19 that could significantly improve testing and long-term monitoring of the disease. More...
13 Jan 2021
Image: Sean Paz, co-author and a graduate student in FAU’s Schmidt College of Medicine, loads COVID-19 tests in a PCR (polymerase chain reaction) machine (Photo courtesy of FAU).

New Simplified Rapid COVID-19 Testing Protocol Requires Less Labor, Expertise and Equipment

A simplified COVID-19 testing protocol that offers a distinct advantage over the standard viral or universal transport medium (VTM) can detect minimal quantities of the SARS-CoV-2 using samples from both upper respiratory tract swabs (nasal and throat) as well as saliva, and can be used in research laboratories with minimal molecular biology equipment and expertise. More...
13 Jan 2021

Snibe Diagnostic’s Maglumi SARS-CoV-2 Neutralizing Antibody Assay Receives CE Mark

Snibe Diagnostic (Shenzhen, China) has received CE marking for its Maglumi SARS-CoV-2 Neutralizing Antibody Assay. More...
12 Jan 2021

FDA Monitoring Impact of SARS-CoV-2 Mutations on Results of Authorized COVID-19 Molecular Tests

The US Food and Drug Administration (FDA; Silver Spring, MD, USA) has alerted clinical laboratory staff and health care providers that it is monitoring the potential impact of viral mutations, including an emerging variant from the UK known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests. More...
11 Jan 2021
Image: An image of the COVID-19 test chip made by aerosol jet nanoparticle 3D printing (Photo courtesy of Carnegie Mellon University)

COVID-19 Test Chip Made by Aerosol Jet Nanoparticle 3D Printing Detects SARS-CoV-2 Antibodies in 10-12 Seconds

An advanced nanomaterial-based biosensing platform that detects antibodies specific to SARS-CoV-2 within seconds can also help to quantify patient immunological response to the new vaccines with precision. More...
11 Jan 2021

Siemens IL-6 Test for COVID-19 Response Granted FDA Emergency Use Authorization

Siemens Healthineers (Erlangen, Germany) has been granted an Emergency Use Authorization by the US Food and Drug Administration for its laboratory-based IL-6 assay to measure the presence of interleukin-6 in human serum or plasma. More...
08 Jan 2021
Copyright © 2000-2021 Globetech Media. All rights reserved.